Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H12N4O3S |
| Molecular Weight | 280.303 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=N1
InChI
InChIKey=WMPXPUYPYQKQCX-UHFFFAOYSA-N
InChI=1S/C11H12N4O3S/c1-18-11-6-10(13-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,14,15)
| Molecular Formula | C11H12N4O3S |
| Molecular Weight | 280.303 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.goldbio.com/product/3383/sulfamonomethoxine
http://ft.chqmarket.com/en/1059-compound-sulfamonomethoxine-sodium-injection-baclean.html
Curator's Comment: description was created based on several sources, including
https://www.goldbio.com/product/3383/sulfamonomethoxine
http://ft.chqmarket.com/en/1059-compound-sulfamonomethoxine-sodium-injection-baclean.html
Sulfamonomethoxine is a long-acting sulfonamide antibiotic. It is active against Streptococcus spp. (Including Streptococcus pneumoniae, Enterococcus spp.), Staphylococcus spp., Escherichia coli, Shigella spp., some strains of Proteus spp., Neisseria gonorrhoeae, Neisseria meningitides. Sulfamonomethoxine also active against Chlamydia spp., Toxoplasma gondii, Plasmodium. Rapidly absorbed from the gastrointestinal tract, it penetrates the BBB. The relatively low toxicity. Sulfamonomethoxine is a competitive inhibitor of dihydropteroate synthetase used to block the synthesis of folic acid. By preventing the production of folate in bacteria, the sulfonamide antibiotics ultimately suppress bacterial DNA replication.
Approval Year
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
2130.6 mg × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1981528/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMONOMETHOXINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
2489.4 mg × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1981528/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMONOMETHOXINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
25 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1981528/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMONOMETHOXINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
29.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1981528/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMONOMETHOXINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
8.1% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1981528/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMONOMETHOXINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
7.4% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1981528/ |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
SULFAMONOMETHOXINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
20.3% |
SULFAMONOMETHOXINE serum | Homo sapiens |
Doses
| Dose | Population | Adverse events |
|---|---|---|
1 g 1 times / day multiple, oral Recommended Dose: 1 g, 1 times / day Route: oral Route: multiple Dose: 1 g, 1 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Headache, Skin rash... Other AEs: Headache Sources: Skin rash Leukopenia Drug fever |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Drug fever | 1 g 1 times / day multiple, oral Recommended Dose: 1 g, 1 times / day Route: oral Route: multiple Dose: 1 g, 1 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
|
| Headache | 1 g 1 times / day multiple, oral Recommended Dose: 1 g, 1 times / day Route: oral Route: multiple Dose: 1 g, 1 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
|
| Leukopenia | 1 g 1 times / day multiple, oral Recommended Dose: 1 g, 1 times / day Route: oral Route: multiple Dose: 1 g, 1 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
|
| Skin rash | 1 g 1 times / day multiple, oral Recommended Dose: 1 g, 1 times / day Route: oral Route: multiple Dose: 1 g, 1 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Sample Use Guides
adult: 1 tablet per day (500 mg- 1 g per day)
children: 25 mg/kg per day at the first day, then 12,5 mg/kg per day
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2730215
It was shown that 9 strains of P. mallei were sensitive to sulfanilamides and their combinations with trimethoprim: sulfamonomethoxine + trimethoprim (2.5:1), etc. The activity of the sulfamonomethoxine combination with trimethoprim (sulfate) was lower.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:35 GMT 2025
by
admin
on
Mon Mar 31 18:10:35 GMT 2025
|
| Record UNII |
U700P169W2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QJ01EQ18
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
||
|
WHO-VATC |
QJ01EW17
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000083273
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
5332
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
C72853
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL462990
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
1220-83-3
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
DTXSID8045351
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
1020
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
2519
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
757862
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
SUB10716MIG
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY | |||
|
U700P169W2
Created by
admin on Mon Mar 31 18:10:35 GMT 2025 , Edited by admin on Mon Mar 31 18:10:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
SOLVATE->ANHYDROUS | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |